Medtronic Launches VitalFlow: A Next-Generation Portable ECMO System

Sep 28, 2024 22:15 CST Updated 22:15

Medtronic

Chronic Disease Medical Device and Therapy Developer

Medtronic Announces the Launch of a New ECMO Product ---VitalFlow, which is aA Configurable Single-System ECMO Solution for Simplicity and Performance. This technology allowsBedside care and intra-hospital transport have become seamless, providing doctors and clinicians with a simpler, smarter, and more reliable ECMO experience.

Executive Evaluation

"The launch of this technology further underscores Medtronic's unwavering commitment to developing life-restoring medical devices that meet acute and chronic cardiopulmonary clinical needs, and demonstrates our continued dedication to this important field. This announcement builds on our recent acquisitions, including the Viant Medical contract manufacturing site and the Penditure left atrial appendage occluder. Clinicians can continue to expect a bold and distinctive pace of innovation globally, focused on meeting diverse clinical needs while enhancing our ability to address the needs of all cardiac surgery patients."

"After collecting feedback from hundreds of clinicians with different ECMO specialties, we were able to design VitalFlow to meet the most pressing unmet needs of ECMO systems in terms of simplicity, configurability, and high performance."VitalFlowThe simplicity allows multiple users with different levels of comfort to confidently and efficiently serve patients. It can be easily carried across various departments within the hospital and offers durable and reliable performance.”

---Karim Bandali MedtronicPresident of Cardiovascular Portfolio, Cardiac Surgery Business

"Clinicians in the ECMO field have evolving needs.The demand for innovative solutions and comprehensive commitment across various disease states is growing. Clinicians have higher expectations of Medtronic, and we are uniquely positioned to meet these needs, advance treatment options, and better serve patients.。”

---Pieter Kappetein Chief Medical Officer of Cardiac Surgery at Medtronic

ECMO (Extracorporeal Membrane Oxygenation) refers to a circuit that directly oxygenates and removes carbon dioxide from the blood through an extracorporeal gas exchange device (commonly known as a membrane oxygenator).Most commonly used for life-threatening heart failure or lung failure to allow the heart and/or lungs to rest and heal. It is also used as a bridge option for further treatments such as heart or lung transplantation, heart assist devices, or left ventricular assist devices (LVAD).

Traditional ECMO systems are bulky and typically can only be used bedside. Transporting them for use in hospital wards, operating rooms, and other locations is an extremely challenging task.VitalFlowMake ECMO a mobile, portable life-saving device that can be moved from the ward to the operating room or anywhere in the hospital as needed.VitalFlowSimplicity and portability address critical clinical needs.

VitalFlow

VitalFlowOriginating from the acquisition of MC3 Cardiopulmonary in March this year.MC3 CardiopulmonarY is an innovative medical device company established in 1991. It is currently one of the global leaders in the ECMO field.Compared with products from Getinge Group, LivaNova, and other companies, the biggest advantage of ECMO products lies in their simplicity, compact design, and ease of use.

Previously, Medtronic's ECMO products were all produced byMC3 Cardiopulmonary provided, eight years agoMedtronic ObtainsMC3 CardiopulmonarGlobal Exclusive of y ProductDistributionRights. Currently, the ECMO series products sold by Medtronic are:NAUTILUS、CRESCENTCatheterAll are derived fromMC3 Cardiopulmonary。

VitalFlowIt is Medtronic andMC3 Cardiopulmonary: The Most Disruptive ECMO Product in Eight Years of Collaboration.

VitalFlowDesign Concept andMC3 CardiopulmonarLike the previous product, it adopts a simple and compact design. According to the public information disclosed by Medtronic:

VitalFlow is a configurable single-system extracorporeal membrane oxygenation (ECMO) system designed to provide a simple design and high-performance ECMO product.VitalFlow adoptsA large, intuitive touchscreen that consolidates real-time performance data and provides configurability,And adopts the proven Medtronic Nautilus™ ECMO oxygenator design, which achieves long-term stable high performance.

Medtronic describes it asBridging the Gap Between Bedside Care and Intra-Hospital Transport. The goal is to provide physicians and clinicians with a simpler, smarter extracorporeal membrane oxygenation experience.Addressed the long-overlooked genuine clinical needs in practice.

Medtronic

Medtronic(Medtronic, Inc.) was founded in 1949, headquarteredHeadquartered in Minneapolis, Minnesota, USA, is the world's largest medical technology company, committed to providing lifelong treatment solutions for patients with chronic diseases.Medtronic's main products cover arrhythmia, heart failure, vascular diseases, heart valve replacement, extracorporeal heart support, minimally invasive heart surgery, malignant and non-malignant pain, movement disorders, diabetes, gastrointestinal diseases, urinary system diseases,Spinal diseases, neurological disorders, and surgeries in ophthalmology, otolaryngology, and other related fields.